Competitive intelligence
Side-by-side comparison
Up to six companies on the same rows. Empty cells say what is missing rather than hiding it.
3 of 6 columns
Comparison
| Attribute | PACIFIC TOXICOLOGY LABORATORIES4.7remove | KaiAvora Health, LLC4.8remove | Brilliskin, Inc.4.7remove |
|---|---|---|---|
| Signal scores | |||
| Radar composite | 4.7 | 4.8 | 4.7 |
| IPO signal score | 9.5 | 9.5 | 9.4 |
| Tokenization signal score | 0.0 | 0.0 | 0.0 |
| On-chain readiness | 0.0 | 0.0 | 0.0 |
| Momentum | STABLE+2.7 | STABLE0.0 | STABLE+2.3 |
| Company | |||
| Stage | private | private | private |
| Sector | Health Care | Health Care | Health Care |
| Headquarters | CHATSWORTH, United States | MEDFORD, United States | ASTORIA, United States |
| Founded | not on record | 2026 | 2025 |
| Employees | not on record | not on record | not on record |
| Capital | |||
| Latest valuation | not on record | not on record | not on record |
| Total funding | $250K | $300K | $25K |
| Latest round | Private Placement $250K | Private Placement $300K | Private Placement $25K |
| Investors on record | 0 | 0 | 0 |
| Evidence | |||
| Institutional relationships | 0 | 0 | 0 |
| Active signals | 1 | 1 | 1 |
| Confidence | 53% | 53% | 53% |
IPO Radar is a research and intelligence tool. Scores are signal scores derived from public evidence — they are not calibrated probabilities and not investment advice. FACT, INFERENCE and PREDICTION are kept separate, and every event links to its source.